Predict severe health events with SomaSignal® tests
SomaSignal tests give patients, providers, and payers more accurate, dynamic, and trusted health information by revealing clinically significant insights specific to the patient across many areas of health.
What are SomaSignal tests?
SomaSignal tests expose early biologic signs that a patient may be headed for a severe health event, revealing whether existing treatments are adequately reducing risk or if adaptations are needed.
How do SomaSignal tests work for clinical use?
Order a SomaSignal test from a licensed physician
Visit a lab and have a blood sample drawn
Physician receives test results within two to three weeks and schedules a follow-up consultation
SomaSignal tests for clinical use
Predicts the absolute risk of a cardiovascular event within 4 years, for patients over 40,
with Type 2 Diabetes, with or without cardiovascular disease or chronic kidney disease.
Primary cardiovascular risk - 4 years
Likelihood of having a cardiovascular event (MI, stroke, heart failure-related hospitalization, cardiac death) within 4 years for patients with no prior history of cardiovascular disease
Secondary cardiovascular risk - 4 years
Predicts the absolute risk of a cardiovascular event within 4 years, for patients 40 years and older, with stable cardiovascular disease, with or without type 2 diabetes, chronic kidney disease, or non-acute symptoms for suspected coronary artery disease
Cardiovascular risk in patients over 65
Predicts the absolute risk of a cardiovascular event within 4 years, for patients older than 65 years, without known cardiovascular disease, with or without type 2 diabetes
Heart failure prognosis - HFpEF
Predicts the risk of all-cause death within 12 months in patients over 18, with stable heart failure and preserved ejection fraction (HFpEF)
Heart failure prognosis - HFrEF
Predicts the risk of all-cause death within 12 months in patients over 18, with stable heart failure and reduced ejection fraction (HFrEF)
Predicts the relative risk of developing at least one of the following conditions of Progressive Chronic Renal Insufficiency (PCRI) within 4 years
Predicts impact of alcohol equivalent to more than 7 drinks per week
Body fat percentage
Predicts percentage of total body fat evaluated with DEXA scan
Cardiorespiratory fitness VO2 max
Predicts peak exercise capacity compared with pulmonary gas exchange assessment during exercise
Predicts likelihood of having impaired glucose tolerance evaluated with 2-hour oral glucose tolerance test
Lean body mass
Predicts amount of lean body mass (in lbs) evaluated with DEXA scan
Predicts likelihood of excess liver fat as compared with liver ultrasound
Resting energy rate
Predicts resting energy expenditure compared with pulmonary gas exchange at rest
Predicts the probability of an individual’s past or current tobacco exposure, for patients 18 years and older
Predicts amount of visceral fat (in lbs) evaluated with a DEXA scan